2018
DOI: 10.1136/thoraxjnl-2017-210943
|View full text |Cite
|
Sign up to set email alerts
|

Incorporating polysomnography into obstructive sleep apnoea phenotyping: moving towards personalised medicine for OSA

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
20
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
9

Relationship

4
5

Authors

Journals

citations
Cited by 23 publications
(21 citation statements)
references
References 20 publications
(24 reference statements)
1
20
0
Order By: Relevance
“…Although the possible protective role of OSA treatment is still uncertain, it could differ among different clinical phenotypes of OSA patients. In that regard, studies are still moving their first steps [18, 175], but some data are available showing different responses depending on OSA phenotype [19]. Such view is confirmed by the recent report developed by European experts on OSA, which suggests that both symptoms and organ damage should be considered when choosing the appropriate treatment for OSA [174].…”
Section: Discussionmentioning
confidence: 99%
“…Although the possible protective role of OSA treatment is still uncertain, it could differ among different clinical phenotypes of OSA patients. In that regard, studies are still moving their first steps [18, 175], but some data are available showing different responses depending on OSA phenotype [19]. Such view is confirmed by the recent report developed by European experts on OSA, which suggests that both symptoms and organ damage should be considered when choosing the appropriate treatment for OSA [174].…”
Section: Discussionmentioning
confidence: 99%
“…Nocturnal sweating is a marker of high nocturnal sympathetic activity and might represent associated comorbidities and poor sleep quality. The role of restless leg syndrome and periodic leg movements is important and the association of obstructive sleep apnoea with PLMs/poor sleep has been recently shown to be a deadly association for cardiovascular diseases 22,23 . Our data complement this observation by showing that this OSA-PLMs phenotype is also at high risk of sleepiness-related accidents, a finding that should be considered for the purpose of risk stratification in clinical practice 24 .…”
Section: Discussionmentioning
confidence: 99%
“…Only half of the OSA patients are symptomatic and a significant percentage of subjects are referred and treated with the goal of mitigating their cardiometabolic risk. The co‐morbidities are of major importance because they have a significant impact on OSA patients' healthcare use and mortality . Continuous positive airway pressure (CPAP), the first‐line therapy for OSA, is highly effective in terms of symptom improvement even in minimally symptomatic patients who initially complain of fatigue and non‐restorative sleep .…”
Section: Introductionmentioning
confidence: 99%
“…The co-morbidities are of major importance because they have a significant impact on OSA patients' healthcare use and mortality. 3,4 Continuous positive airway pressure (CPAP), the first-line therapy for OSA, is highly effective in terms of symptom improvement even in minimally symptomatic patients who initially complain of fatigue and nonrestorative sleep. 5 CPAP has a limited impact on the reduction in the burden of co-morbidities, 6 and comorbidities might affect the effectiveness of CPAP to normalize the apnoea-hypopnoea index (AHI) and may hinder CPAP adherence.…”
Section: Introductionmentioning
confidence: 99%